Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells

Virus Research

Volumn 167, Issue 1, 2012, Pages 48-55

  Wang, Houping ^a   Moon, Sungsil ^a   Wang, Yuhuan ^a   Jiang, Baoming ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Astrovirus; Cytokine; Enterovirus; Interference; Rotavirus; Toll like receptor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; ROTAVIRUS VACCINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROVIRUS; ASTROVIRUS INFECTION; CELL STRAIN CACO 2; CONTROLLED STUDY; ENTEROVIRUS; ENTEROVIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LOWEST INCOME GROUP; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAVIRUS; ROTAVIRUS INFECTION; VIRUS REPLICATION;

ASTROVIRIDAE INFECTIONS; CACO-2 CELLS; COINFECTION; CYTOKINES; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; INTESTINES; MAMASTROVIRUS; ROTAVIRUS; ROTAVIRUS INFECTIONS; TOLL-LIKE RECEPTORS; VIRUS REPLICATION;

ASTROVIRIDAE; ENTEROVIRUS; ROTAVIRUS;

EID: 84861483887     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.04.001     Document Type: Article

References (58)

1. Armah G.E., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):606-614.
2. Bahrami B., et al. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. Journal of Applied Microbiology 2011, 110(1):353-363.
3. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 1996, 14:649-683.
4. Bass D.M. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 1997, 113(1):81-89.
5. Brandt C.D., et al. Simultaneous infections with different enteric and respiratory tract viruses. Journal of Clinical Microbiology 1986, 23(1):177-179.
6. Caceres V.M., Sutter R.W. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clinical Infectious Diseases 2001, 33(4):531-541.
7. Casola A., et al. Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation. Virology 2002, 298(1):8-19.
8. Chen K.S., et al. Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine 2008, 46(11):1609-1616.
9. Clouse K.A., et al. Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. Journal of Immunology 1989, 143(2):470-475.
10. Cuadras M.A., et al. Gene expression pattern in Caco-2 cells following rotavirus infection. Journal of Virology 2002, 76(9):4467-4482.
11. De Marco G., et al. Rotavirus induces a biphasic enterotoxic and cytotoxic response in human-derived intestinal enterocytes, which is inhibited by human immunoglobulins. Journal of Infectious Diseases 2009, 200(5):813-819.
12. Doyle M., Holland J.J. Virus-induced interference in heterologously infected HeLa cells. Journal of Virology 1972, 9(1):22-28.
13. Fach S.J., et al. Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Veterinary Immunology and Immunopathology 2010, 136(1-2):55-64.
14. Fensterl V., Sen G.C. Interferons and viral infections. Biofactors 2009, 35(1):14-20.
15. Giammanco G., et al. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. European Journal of Epidemiology 1988, 4(1):121-123.
16. Glass R.I., et al. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children. Advances in Experimental Medicine and Biology 1991, 310:249-254.
17. Glass R.I., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368(9532):323-332.
18. Goveia M.G., et al. Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine. Annals of the New York Academy of Sciences 2011, 1222:14-18.
19. Goveia M.G., et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatric Infectious Disease Journal 2007, 26(12):1099-1104.
20. Guerrant R.L., et al. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Reviews of Infectious Diseases 1990, 12(Suppl. 1):S41-S50.
21. Isa P., et al. Rotavirus cell entry. Future Virology 2008, 3(2):135-146.
22. Jourdan N., et al. Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. Journal of Virology 1997, 71(11):8268-8278.
23. Kumar Mohanty S., et al. Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis via Mip2/Cxcl2. Pediatric Research 2010.
24. Lecce J.G., et al. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Molecular Biotherapy 1990, 2(4):211-216.
25. Lin Y., et al. Th17 cytokines and vaccine-induced immunity. Seminars in Immunopathology 2010, 32(1):79-90.
26. Lynch M., et al. Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism. Pediatrics 2006, 117(5):e827-e832.
27. Madhi S.A., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362(4):289-298.
28. Manuse M.J., Parks G.D. TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology 2010, 397(1):231-241.
29. McNeal M.M., et al. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein. Viral Immunology 2007, 20(4):571-584.
30. Migasena S., et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995, 13(2):168-174.
31. Miller M.D., Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Critical Reviews in Immunology 1992, 12(1-2):17-46.
32. Mirzayeva R., et al. Evaluation of rotavirus vaccines in Asia-are there lessons to be learnt?. Vaccine 2009, 27(Suppl. 5):F120-F129.
33. Moon S.S., et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatric Infectious Disease Journal 2010, 29(10):919-923.
34. Moser L.A., et al. Astrovirus increases epithelial barrier permeability independently of viral replication. Journal of Virology 2007, 81(21):11937-11945.
35. Obert G., et al. Rotavirus-induced structural and functional alterations in tight junctions of polarized intestinal Caco-2 cell monolayers. Journal of Virology 2000, 74(10):4645-4651.
36. Parashar U.D., et al. Global mortality associated with rotavirus disease among children in 2004. Journal of Infectious Diseases 2009, 200(Suppl 1):S9-S15.
37. Patel M.M., et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. New England Journal of Medicine 2011, 364(24):2283-2292.
38. Pinto M., et al. Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture. Biology of the Cell 1983, 47(3):323-330.
39. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology 2005, 5(5):375-386.
40. Pott J., et al. IFN-{lambda} determines the intestinal epithelial antiviral host defense. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(19):7944-7949.
41. Redecke V., et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. Journal of Immunology 2004, 172(5):2739-2743.
42. Rodriguez L.S., et al. Immunomodulators released during rotavirus infection of polarized caco-2 cells. Viral Immunology 2009, 22(3):163-172.
43. Rollo E.E., et al. The epithelial cell response to rotavirus infection. Journal of Immunology 1999, 163(8):4442-4452.
44. Rozinov M.N., Fields B.N. Interference following mixed infection of reovirus isolates is linked to the M2 gene. Journal of Virology 1994, 68(10):6667-6671.
45. Rozinov M.N., Fields B.N. Interference of reovirus strains occurs between the stages of uncoating and dsRNA accumulation. Journal of General Virology 1996, 77(Pt 7):1425-1429.
46. Ruiz-Palacios G.M., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 2006, 354(1):11-22.
47. Schwers A., et al. Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2). Annales de Recherches Veterinaires 1985, 16(3):213-218.
48. Serazin A.C., et al. Improving the performance of enteric vaccines in the developing world. Nature Immunology 2010, 11(9):769-773.
49. Sheth R., et al. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 1996, 221(2):251-259.
50. Steele A.D., et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine 2010, 28(39):6542-6548.
51. Tate J.E., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124(2):465-471.
52. Tregnaghi M.W., et al. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatric Infectious Disease Journal 2011, 30(6):e103-e108.
53. Vesikari T., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006, 354(1):23-33.
54. Wagner R.R. Viral interference. Some considerations of basic mechanisms and their potential relationship to host resistance. Bacteriological Reviews 1960, 24(1):151-166.
55. Xu J., et al. Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea. Clinical and Experimental Immunology 2006, 144(3):376-381.
56. Xu J., et al. Rotavirus and coxsackievirus infection activated different profiles of toll-like receptors and chemokines in intestinal epithelial cells. Inflammation Research 2009, 58(9):585-592.
57. Zaman K., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(9741):615-623.
58. Zaman K., et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009, 27(9):1333-1339.